Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekjnCfbwocfbrymlWxhv

  ADVERTISEMENT  
February 13, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Bio-scaffold may allow for regrowth of broken bones
    Researchers from the U.K. used a method called "solvent blending" to create a degradable, plastic bio-scaffold that can be inserted into broken bones to induce them to regrow. Stem cells from the bone marrow are carried by the blood through the scaffold, where they can attach and generate new bone tissue. The researchers are preparing for human trials. The findings were published in the journal Advanced Functional Materials. Medical News Today (2/11) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
How much do you hate your anti-Fyb?
Tired of sub-par reactions? Quotient has a newly approved anti-Fyb, as well as hard-to-find Anti-s, Anti-Wra and other rare antisera that are worth a try. Find out how the one company focused on manual testing can serve you in 2013 and beyond.

  Science & Health 
  • Global cost for Chagas' disease estimated at $7B
    The global cost of Chagas' disease has reached about $7 billion a year, greater than similar estimates for cervical cancer and cholera, according to an analysis in the journal Lancet Infectious Diseases. In the U.S., costs linked to the disease could be as high as $800 million a year. The study illustrates the need to devote more resources to addressing the illness, a researcher said. National Public Radio/Shots blog (2/10) LinkedInFacebookTwitterEmail this Story
  • Brain cells used to treat lack of myelin cells in mice
    Researchers have turned human skin cells into induced pluripotent stem cells that were then transformed into oligodendrocyte progenitors. Oligodendrocytes produce myelin cells, which researchers hope can be used in the treatment of multiple sclerosis. Transplanting the engineered cells into mice led to the production of myelin without the growth of tumors, according to the study in the journal Cell Stem Cell. Human trials are anticipated to start in 2015. Gizmag (2/12) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Facebook could help people prevent HIV infection, study says
    Social networking tools including Facebook show promise in helping prevent HIV infection among people who belong to at-risk groups, according to a study in the journal Sexually Transmitted Diseases. "This study helps direct us toward that goal by suggesting that participants will use social media to learn about HIV prevention and that those who talk about HIV prevention over social networking groups are not just talking about it -- they are acting on their words by getting an HIV test," said researcher Sean Young. Healthcare Informatics online (2/12) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • CDC: Hospitals made steady progress in curbing some infections
    A CDC report released on Tuesday found that the rates of central line-associated bloodstream infections declined by 41% and surgical site infections fell by 17% in U.S. hospitals since 2008. However, catheter-associated urinary tract infections have not declined further since 2010, possibly due to the number of catheter days holding steady in critical-care settings. CDC Director Dr. Tom Frieden called on hospitals to do more to control and track infections. Modern Healthcare (subscription required) (2/12), Nurse.com (2/12) LinkedInFacebookTwitterEmail this Story
The Buzz(CORPORATE ANNOUNCEMENTS)

Registration Now Open - April 9, 2013 PACT Workshop
“Developing Cellular Therapies: From Preclinical Safety to Clinical Evaluation”. Hosted by University of Wisconsin, Waisman Biomanufacturing (WB), Madison, WI. No charge for attendance. Click here for more details.


  Government & Regulatory 
  • HHS-drafted health rules advance to final review
    Two sets of Affordable Care Act health regulations from HHS have been sent to the White House for final review. One sets standards for essential health benefits and a timeline for the accreditation of qualified health plans in health insurance exchanges. The second concerns the protection of health insurers against financial losses. The Hill (2/11) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Reminder: AABB offers self-assessment module credits
    AABB is an approved provider of Maintenance of Certification Part II: Lifelong Learning and Self-Assessment Module credits. SAM credits are available for select education sessions from past AABB Annual Meetings. For more information, individuals may contact AABB's Education and Professional Development Department. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

  SmartQuote 
Several excuses are always less convincing than one."
--Aldous Huxley,
British author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information